Search Results - "Magrini, S. M."

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes by Barbera, F, Triggiani, L, Buglione, M, Ghirardelli, P, Vitali, P, Caraffini, B, Borghetti, P, Greco, D, Bardoscia, L, Pasinetti, N, Costa, L, Maddalo, M, Ghedi, B, La Face, B, Magrini, SM

“…Background/aim: Low dose rate brachytherapy has been used as salvage therapy for locally recurrent prostate cancer (PC) after primary external beam radiation…”
Get full text

A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study by Nicosia, L., Franceschini, D., Perrone-Congedi, F., Casamassima, F., Gerardi, M.A., Rigo, M., Mazzola, R., Perna, M., Scotti, V., Fodor, A., Iurato, A., Pasqualetti, F., Gadducci, G., Chiesa, S., Niespolo, R.M., Bruni, A., Alicino, G., Frassinelli, L., Borghetti, P., Di Marzo, A., Ravasio, A., De Bari, B., Sepulcri, M., Aiello, D., Mortellaro, G., Sangalli, C., Franceschini, M., Montesi, G., Aquilanti, F.M., Lunardi, G., Valdagni, R., Fazio, I., Scarzello, Giovanni, Corti, L., Vavassori, V., Maranzano, E., Magrini, S.M., Arcangeli, S., Gambacorta, Maria Antonietta, Valentini, V., Paiar, F., Ramella, S., Di Muzio, N.G., Livi, L., Jereczek-Fossa, B.A., Osti, M.F., Scorsetti, M., Alongi, F.

“…•SABR provides high rates of local control to lung oligometastases.•Local control of colorectal lung metastases seems lower compared to other tumors.•We…”
Get full text

Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy by Ingrosso, G., Detti, B., Fodor, A., Caini, S., Borghesi, S., Triggiani, L., Trippa, F., Russo, D., Bruni, A., Francolini, G., Lancia, A., Marinelli, L., Di Muzio, N., Livi, L., Magrini, S. M., Maranzano, E., Musio, D., Aristei, C., Valeriani, M.

“…Objectives To report outcomes of stereotactic body radiotherapy (SBRT) in metastatic castration-resistant prostate cancer (mCRPC) patients with…”
Get full text

Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study by Re, A., Ferrari, S., Frata, P., Pizzocaro, C., Crippa, C., Tucci, A., Facchetti, F., Grazioli, L., Magrini, S.M., Rossi, G.

“…Background: Tailoring treatment intensity is critical in Hodgkin's lymphoma (HL). Ongoing prognostic parameters may be an useful adjunct to pretreatment…”
Get full text

COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy by Jereczek-Fossa, B.A., Palazzi, M.F., Soatti, C.P., Cazzaniga, L.F., Ivaldi, G.B., Pepa, M., Amadori, M., Antognoni, P., Arcangeli, S., Buffoli, A., Beltramo, G., Berlinghieri, S., Bignardi, M., Bracelli, S., Bruschieri, L., Castiglioni, S., Catalano, G., Di Muzio, N., Fallai, C., Fariselli, L., Filippi, A.R., Gramaglia, A., Italia, C., Lombardi, F., Magrini, S.M., Nava, S., Orlandi, E., Pasinetti, N., Sbicego, E.L., Scandolaro, L., Scorsetti, M., Stiglich, F., Tonoli, S., Tortini, R., Valdagni, R., Vavassori, V., Marvaso, G.

Get full text

Stage I seminoma of the testis: a bi‐institutional retrospective analysis of patients treated with radiation therapy only by Santoni, R., Barbera, F., Bertoni, F., De Stefani, A., Livi, L., Paiar, F., Scoccianti, S., Magrini, S.M.

“…OBJECTIVE To analyse relapse patterns, toxicity and second malignancy in patients with stage I pure germ cell testicular tumours, treated in 1970–1999…”
Get full text

Stereotactic radiotherapy and cytokines: preliminary analysis in oligometastatic Non-Small-Cell lung cancer by Borghetti, P, Guerini, A E, Colosini, A, Facheris, G, Gandolfo, C, Triggiani, L, Bruni, A, D'Angelo, E, Cusi, M Grazia, Magrini, S M, Bresciani, R, Nardone, V

Get full text

Nasopharyngeal carcinoma in a low incidence European area: A prospective observational analysis from the Head and Neck Study Group of the Italian Society of Radiation Oncology (AIRO) by Tonoli, S., Alterio, D., Caspiani, O., Bacigalupo, A., Bunkheila, F., Cianciulli, M., Merlotti, A., Podhradska, A., Rampino, M., Cante, D., Bruschieri, L., Gatta, R., Magrini, S. M.

“…Purpose To evaluate the outcomes with respect to long-term survival and toxicity in patients with nasopharyngeal carcinoma (NPC) treated in a European country…”
Get full text

Role of external beam radiotherapy in the treatment of relapsing meningioma by Buglione, M., De Bari, B., Trevisan, F., Ghirardelli, P., Pedretti, S., Triggiani, L., Magrini, S. M.

“…The role of radiotherapy in the treatment of relapsing meningiomas is not well established. Data of patients treated with radiotherapy for a relapsing…”
Get full text

Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study by Biti, G P, Cimino, G, Cartoni, C, Magrini, S M, Anselmo, A P, Enrici, R M, Bellesi, G P, Bosi, A, Papa, G, Giannarelli, D

“…To compare the effectiveness of chemotherapy (CHT) with extended-field radiotherapy (RT) in the treatment of early-stage Hodgkin's disease (ESHD), we report an…”
Get more information

Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma: A comparison with intensity-modulated radiotherapy and a spot size variation assessment by Lorentini, S., Amichetti, M., Spiazzi, L., Tonoli, S., Magrini, S.M., Fellin, F., Schwarz, M.

“…Purpose Intensity-modulated radiation therapy (IMRT) is the state-of-the-art treatment for patients with malignant pleural mesothelioma (MPM). The goal of this…”
Get full text

In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study by Aristei, C, Santucci, A, Corvò, R, Gardani, G, Ricardi, U, Scarzello, G, Magrini, S M, Donato, V, Falcinelli, L, Bacigalupo, A, Locatelli, F, Aversa, F, Barbieri, E

“…The aim of this study was to determine whether parameters related to TBI impacted upon OS and relapse in patients with acute leukemia in CR who underwent…”
Get full text

Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology) by Scoccianti, Silvia, Magrini, Stefano Maria, Ricardi, Umberto, Detti, Beatrice, Krengli, Marco, Parisi, Salvatore, Bertoni, Filippo, Sotti, Guido, Cipressi, Samantha, Tombolini, Vincenzo, Dall'oglio, Stefano, Lioce, Marco, Saieva, Calogero, Buglione, Michela, Mantovani, Cristina, Rubino, Giovanni, Muto, Paolo, Fusco, Vincenzo, Fariselli, Laura, de Renzis, Costantino, Masini, Laura, Santoni, Riccardo, Pirtoli, Luigi, Biti, Giampaolo

“…Although the evidence for the benefit of adding temozolomide (TMZ) to radiotherapy (RT) is limited to glioblastoma patients, there is currently a trend toward…”
Get full text

In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study by Aristei, C, Santucci, A, Corvo, R, Gardani, G, Ricardi, U, Scarzello, G, Magrini, Sm, Donato, V, Falcinelli, L, Bacigalupo, A, Locatelli, F, Aversa, F, Barbieri, E

Get full text

Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study by De Bari, B., Vallati, M., Gatta, R., Simeone, C., Girelli, G., Ricardi, U., Meattini, I., Gabriele, P., Bellavita, R., Krengli, M., Cafaro, I., Cagna, E., Bunkheila, F., Borghesi, S., Signor, M., Di Marco, A., Bertoni, F., Stefanacci, M., Pasinetti, N., Buglione, M., Magrini, S. M.

“…ABSTRACT We tested and compared performances of Roach formula, Partin tables and of three Machine Learning (ML) based algorithms based on decision trees in…”
Get full text

Clinical similarities: an innovative approach for supporting medical decisions by Vallati, M, Gatta, R, De Bari, B, Magrini, S M

“…Taking decisions in the medical domain is a very complex task. The context is strongly affected by uncertainty and the possible undesired side effects of the…”
Get more information

Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis by Bandera, L, La Face, B, Antonioli, C, Galelli, M, Ghedi, B, Fiume, A, Buglione, M, Magrini, S M, Sartori, E

“…To add to the existing outcome data regarding radical radiotherapy (RT) for FIGO Stage I and II cervical cancer in a mono-institutional series and to evaluate…”
Get more information

Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution by Biti, G, Cellai, E, Magrini, S M, Papi, M G, Ponticelli, P, Boddi, V

“…To define the risk of having a second malignant neoplasm (ST) in different subsets of Hodgkin's disease patients and possibly to identify potentially avoidable…”
Get more information

A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian Centres from 1977 to 2000. Part I: evolving technical choices and survival by Tonoli, S., Magrini, S. M., Costa, L., Paiar, F., Simontacchi, G., Scotti, V., Pasinetti, N., Barca, R., Barbieri, D., De Stefani, A., Cellai, E., Buglione, M., Biti, G.

“…Purpose The authors sought to define treatment results according to the different accrual periods and clinical-therapeutic features in a large series of…”
Get full text

A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian Centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns by Magrini, S. M., Tonoli, S., Costa, L., Pasinetti, N., Paiar, F., Livi, L., Simontacchi, G., Meattini, I., Pegurri, L., Borghetti, P., Frata, P., Ponticelli, P., Buglione, M., Biti, G.

“…Purpose The authors sought to define toxicity patterns according to the different accrual periods and clinical-therapeutic features in a large series of…”
Get full text